Text Size

Clinical outcomes of Preserflo MicroShunt implant procedure in open‑angle glaucoma patients – a 1000 eyes case-series; including subanalysis of combined cataract-glaucoma surgery and standalone surgery in pseudophakic eyes

Klabe, K.; Werth, J.P.; Kaymak, H. ; Fricke, A.


  • 2026
  • Graefe's Archive for Clinical and Experimental Ophthalmology
View publication
  • Therapeutic Area

    Glaucoma

  • Categories

    Post-Approval studies/RWE, Sponsored/funded by Santen

  • Affiliations

    Internationale Innovative Ophthalmochirurgie, Martin-Luther-Platz 22/26, Düsseldorf 40212, Germany; Gottfried O.H. Naumann-Institut für Epidemiologie und Prävention der Myopie, Universitätsklinikum des Saarlandes, Augenklinik / Gebäude 22, Kirrberger Straße 100, Homburg/Saar 66421, Germany

Related Publications

Long-term safety and efficacy of sepetaprost, with or without timolol, in patients with open-angle glaucoma or ocular hypertension: results from the randomised, phase 3 ANGEL-J2 study

Inatani M., Tone Y., Ikeda T., Angeles R.


Efficacy and safety of sepetaprost in patients with primary open-angle glaucoma or ocular hypertension: results from the randomised, phase 3 ANGEL-J1 study

Inatani M., Kanamori A., Inai M., Ikeda T., Angeles R.


Müller glia derived EVs promote neurite recovery of an enriched population of retinal ganglion like cells derived from hESC retinal organoids after damage

Eastlake K, Lamb WDB, Tracey-White D, Shibagaki K, Khaw PT, Jayaram H, Limb GA


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022